Deutsche Bank reiterates their Buy rating on Genzyme (NASDAQ: GENZ) with an $80 price target. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE